Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Ellen F. Vieux
Observed names:
Ellen Vieux,
Vieux, Ellen F.
Institution:
Odyssey Therapeutics (United States)
Observed institutions:
Broad Institute,
Howard Hughes Medical Institute,
Washington University in St. Louis,
C4 Therapeutics (United States),
Odyssey Therapeutics (United States),
Stanley Center for Psychiatric Research,
Massachusetts Institute of Technology
show all 7
ORCID:
0000-0003-3815-4366
Observed ORCID:
0000-0003-3815-4366
OpenAlex ID:
A5014727522
Distinct quaternary structures of the AAA+ Lon protease control substrate degradation
2013
·
Ellen F. Vieux
, Matthew L. Wohlever
, et al.
·
Proceedings of the National Academy of Sciences
·
66
Primer Design for PCR and Sequencing in High-Throughput Analysis of SNPs
2002
·
Ellen F. Vieux
, Pui-Yan Kwok
, et al.
·
BioTechniques
·
47
PDF
High-Throughput Quantitative Assay Technologies for Accelerating the Discovery and Optimization of Targeted Protein Degradation Therapeutics
2021
·
Jeffrey R. Simard
, Linda Lee
, et al.
·
SLAS DISCOVERY
·
34
PDF
Deletion of internal structured repeats increases the stability of a leucine-rich repeat protein, YopM
2011
·
Ellen F. Vieux
, Doug Barrick
·
Biophysical Chemistry
·
18
A Method for Determining the Kinetics of Small-Molecule-Induced Ubiquitination
2021
·
Ellen F. Vieux
, Roman V. Agafonov
, et al.
·
SLAS DISCOVERY
·
17
PDF
Regulation of purine metabolism connects KCTD13 to a metabolic disorder with autistic features
2020
·
Jon M. Madison
, Karen Duong
, et al.
·
iScience
·
13
PDF
N domain of the Lon AAA+ protease controls assembly and substrate choice
2018
·
Breann L. Brown
, Ellen F. Vieux
, et al.
·
Protein Science
·
12
PDF
Abstract 3022: ODY-CDK, a brain-penetrant, selective CDK2 inhibitor that demonstrates antitumor activity in an intracranial CCNE1-amplified breast tumor model
2025
·
Joe Gozgit
, Gerald Lelais
, et al.
·
Cancer Research
·
1
SNP Discovery and PCR‐Based Assay Design: From In Silico Data to the Laboratory Experiment
2003
·
Ellen Vieux
, Gabor Marth
, et al.
·
1
Abstract 1949: In vivo profiling of BET degraders establishes optimal pharmacological properties that showcase distinct biological differences from BET inhibitors
2020
·
Brendon Ladd
, David Cocozziello
, et al.
·
Cancer Research
Distinct Quaternary Structures of Lon Protease Control Substrate Degradation
2013
·
Ellen F. Vieux
, Matthew L. Wohlever
, et al.
·
Biophysical Journal
PDF
Show more works
View as search
Works count:
13
Citation count:
209
H-index:
7
I10-index:
7
Year
Topic
Type